Ambrisentan 5 mg/1
Ambrisentan · TABLET, FILM COATED · Cipla USA Inc.
No Recall History
Plain English
Ambrisentan is a tablet, film coated containing ambrisentan at 5 mg/1, taken oral. Manufactured by Cipla USA Inc..
Key Facts
- Brand Name
- Ambrisentan
- Generic Name
- Ambrisentan
- NDC Code (Product)
69097-386- Manufacturer
- Cipla USA Inc.
- Strength
- 5 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- ANDA210715
- Drug Class
- Endothelin Receptor Antagonist [EPC]
- Marketing Start
- 04/26/2019
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
dyspnoea9,117 reports
death7,173 reports
headache5,693 reports
pneumonia4,353 reports
diarrhoea4,013 reports
nausea3,375 reports
fatigue3,302 reports
dizziness3,065 reports
malaise2,625 reports
fluid retention2,468 reports
Full Prescribing Information
Full prescribing information not available for this product.
Frequently Asked Questions
What is Ambrisentan used for?
Ambrisentan contains Ambrisentan. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is Ambrisentan a controlled substance?
Ambrisentan is not classified as a controlled substance by the DEA.
What is the generic name for Ambrisentan?
The generic name for Ambrisentan is Ambrisentan. There are 4 other brand versions of Ambrisentan.
What is the NDC code for Ambrisentan 5 mg/1?
The NDC (National Drug Code) for Ambrisentan 5 mg/1 is 69097-386, listed by Cipla USA Inc..